Kim E - Search Results

1

Homeostasis limits keratinocyte evolution.

Schenck RO, Kim E, Bravo RR, West J, Leedham S, Shibata D, Anderson ARA. Schenck RO, et al. Among authors: kim e. Proc Natl Acad Sci U S A. 2022 Aug 30;119(35):e2006487119. doi: 10.1073/pnas.2006487119. Epub 2022 Aug 23. Proc Natl Acad Sci U S A. 2022. PMID: 35998218 Free PMC article.

2

Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach.

Kim E, Rebecca V, Fedorenko IV, Messina JL, Mathew R, Maria-Engler SS, Basanta D, Smalley KS, Anderson AR. Kim E, et al. Cancer Res. 2013 Dec 1;73(23):6874-85. doi: 10.1158/0008-5472.CAN-13-1720. Epub 2013 Sep 30. Cancer Res. 2013. PMID: 24080279 Free PMC article.

3

Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma.

Rebecca VW, Massaro RR, Fedorenko IV, Sondak VK, Anderson AR, Kim E, Amaravadi RK, Maria-Engler SS, Messina JL, Gibney GT, Kudchadkar RR, Smalley KS. Rebecca VW, et al. Among authors: kim e. Pigment Cell Melanoma Res. 2014 May;27(3):465-78. doi: 10.1111/pcmr.12227. Epub 2014 Feb 21. Pigment Cell Melanoma Res. 2014. PMID: 24490764 Free PMC article.

4

Bridging scales in cancer progression: mapping genotype to phenotype using neural networks.

Gerlee P, Kim E, Anderson AR. Gerlee P, et al. Among authors: kim e. Semin Cancer Biol. 2015 Feb;30:30-41. doi: 10.1016/j.semcancer.2014.04.013. Epub 2014 May 12. Semin Cancer Biol. 2015. PMID: 24830623 Free PMC article. Review.

5

Phase i trials in melanoma: A framework to translate preclinical findings to the clinic.

Kim E, Rebecca VW, Smalley KS, Anderson AR. Kim E, et al. Eur J Cancer. 2016 Nov;67:213-222. doi: 10.1016/j.ejca.2016.07.024. Epub 2016 Sep 28. Eur J Cancer. 2016. PMID: 27689717 Free PMC article.

6

Cell signaling heterogeneity is modulated by both cell-intrinsic and -extrinsic mechanisms: An integrated approach to understanding targeted therapy.

Kim E, Kim JY, Smith MA, Haura EB, Anderson ARA. Kim E, et al. Among authors: kim jy. PLoS Biol. 2018 Mar 9;16(3):e2002930. doi: 10.1371/journal.pbio.2002930. eCollection 2018 Mar. PLoS Biol. 2018. PMID: 29522507 Free PMC article.

7

Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma.

Smalley I, Kim E, Li J, Spence P, Wyatt CJ, Eroglu Z, Sondak VK, Messina JL, Babacan NA, Maria-Engler SS, De Armas L, Williams SL, Gatenby RA, Chen YA, Anderson ARA, Smalley KSM. Smalley I, et al. Among authors: kim e. EBioMedicine. 2019 Oct;48:178-190. doi: 10.1016/j.ebiom.2019.09.023. Epub 2019 Oct 5. EBioMedicine. 2019. PMID: 31594749 Free PMC article.

8

Adaptive Therapy for Metastatic Melanoma: Predictions from Patient Calibrated Mathematical Models.

Kim E, Brown JS, Eroglu Z, Anderson ARA. Kim E, et al. Cancers (Basel). 2021 Feb 16;13(4):823. doi: 10.3390/cancers13040823. Cancers (Basel). 2021. PMID: 33669315 Free PMC article.

9

A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation.

West J, Adler F, Gallaher J, Strobl M, Brady-Nicholls R, Brown J, Roberson-Tessi M, Kim E, Noble R, Viossat Y, Basanta D, Anderson ARA. West J, et al. Among authors: kim e. Elife. 2023 Mar 23;12:e84263. doi: 10.7554/eLife.84263. Elife. 2023. PMID: 36952376 Free PMC article.

10

Prolonged MEK inhibition leads to acquired resistance and increased invasiveness in KRAS mutant gastric cancer.

Choi KM, Cho E, Kim E, Shin JH, Kang M, Kim B, Han EH, Chung YH, Kim JY. Choi KM, et al. Among authors: kim jy, kim e, kim b. Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):311-318. doi: 10.1016/j.bbrc.2018.11.030. Epub 2018 Nov 19. Biochem Biophys Res Commun. 2018. PMID: 30466782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22,929 results

Search Page